Research FDA Approves Landmark Cancer Therapy; Wilmot Among First to Offer It Oct. 20, 2017 Facebook Twitter LinkedIn Email Skip breadcrumb URMC Home Newsroom News FDA Approves Landmark Cancer Therapy; Wilmot Among First to Offer It
